Israel said Friday it will intensify its 22-month war with Hamas by taking over Gaza City, stirring fears for Palestinian civilians and hostages still held in the shattered enclave.
READ MORESHENZHEN,China,March 17,2025-- MicroAlgo Inc. (NASDAQ: MLGO),(the "Company"or "MicroAlgo"),today announced the introduction of an innovative solution: a multi-simulator collaborati
NEW YORK,March 18,2025-- After selling out in just two days,COSRX\'s highly anticipated The Ceramide Skin Barrier Moisturizer has become a sensation in the skincare world. Fans and skincare enthusiast
The National Asthma Council Australia\'s Sensitive Choice program has recognised Coway\'s Airmega air purifier lineup as being Sensitive Choice approved with the potential to benefit people living wi
DEKRA remains on course despite global economic and political crises STUTTGART,Germany,Nov. 25,2024-- DEKRA could hardly be entering the year of its 100th anniversary on a more future-proof and resil
Buy 1 Get 1 deals,and more duringTraveloka Black Friday—stay tuned for more exciting campaigns this December and year-end!
Beko\'s 1.5°C aligned near-term and net-zero targets are approved by Science Based Targets initiative (SBTi)*
Industry-Leading Features Tailored to Meet the Increasing Demand for Eco-Friendly,Versatile Solutions for Recreation and Work
BOISE,Idaho,Nov. 26,2024-- Lovevery,the global early childhood development brand,today announced the release of The Real Life Play Kitchen. A first-of-its-kind,The Real Life Play Kitchen is unlike t
LOS ANGELES,Nov. 25,2024-- As an emerging brand specializing in sensitive skin repair,Cistto is grounded in skin science and committed to advancing skin health through the latest dermatological breakt
Streamlined workflows on AI-powered 3D content creation platform make XR accessible,affordable,and scalable for businesses of all sizes
SHANGHAI,Nov. 25,2024--LongBio is proud to announce that the National Medical Products Administration (NMPA,China) has approved the Investigational New Drug (IND) application for LP-003,the company\'s
YONGIN,South Korea,Nov. 26,2024-- GC Biopharma and Novel Pharma today announced that the first patient in the US has been dosed in multinational clinical trial with \'GC1130A\',an innovative new drug
© OfficialAffairs
